{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:42:58Z","timestamp":1757454178062,"version":"3.40.5"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2021,8,16]]},"abstract":"<jats:sec>\n<jats:title>Background::<\/jats:title>\n<jats:p>Vitiligo is an auto-immune disease with white-coloured disfiguring patches\nor spots on the skin surface. It is highly prevalent in several corners of the world. This disease\nspreads in different age groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aim::<\/jats:title>\n<jats:p>The main aim of this review is to provide overview of Pathophysiology and Lipid-based nano-carriers for the treatment of vitiligo.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods::<\/jats:title>\n<jats:p> The conventional delivery systems available have limited efficacy due to less retention\nof the drug in the epidermal layer where melanocytes reside. In order to overcome these issues, an\nadvanced delivery system with lipid-based nano-carriers for the treatment of vitiligo was proven to\nbe better as per the literature explored.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results::<\/jats:title>\n<jats:p>This review summarizes the pathophysiology along with novel Lipid-based nano-carriers for the treatment of vitiligo are described well.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion::<\/jats:title>\n<jats:p>Though various treatment regimens are present for the disease, nano-lipid carrier systems\nare significantly gaining importance nowadays, due to their high effectivity in topically acting\non the target site. Nano-lipid carrier systems such as liposomes, ethosomes, transethosomes and\ntransferosomes can be said to be at the top of the list in acting effectively against vitiligo or several\nother tropical diseases.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874467213999201109220714","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T04:21:23Z","timestamp":1605068483000},"page":"306-320","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nano-Lipid-Carriers for the Treatment of Vitiligo: A Recent Update, Pathophysiology and Mechanism of Drug Delivery"],"prefix":"10.1016","volume":"14","author":[{"given":"Supratim","family":"Das","sequence":"first","affiliation":[{"name":"ISF College of Pharmacy, Moga, Punjab, 142001, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhbir","family":"Kaur","sequence":"additional","affiliation":[{"name":"ISF College of Pharmacy, Moga, Punjab, 142001, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jaci.2017.07.011","volume":"140","author":"Frisoli M.L.","year":"2017","unstructured":"Frisoli M.L.; Harris J.E.; Vitiligo: Mechanistic insights lead to novel treatments. J Allergy Clin Immunol 2017,140(3),654-662","journal-title":"J Allergy Clin Immunol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.12659\/MSM.914898","volume":"25","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Li S.; Li C.; Perspectives of new advances in the pathogenesis of vitiligo: from oxidative stress to autoimmunity. Med Sci Monit 2019,25,1017-1023","journal-title":"Med Sci Monit"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.det.2016.11.014","volume":"35","author":"Rashighi M.","year":"2017","unstructured":"Rashighi M.; Harris J.E.; Vitiligo pathogenesis and emerging treatments. Dermatol Clin 2017,35(2),257-265","journal-title":"Dermatol Clin"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.det.2016.11.004","volume":"35","author":"Goh B.K.","year":"2017","unstructured":"Goh B.K.; Pandya A.G.; Presentations, signs of activity, and differential diagnosis of vitiligo. Dermatol Clin 2017,35(2),135-144","journal-title":"Dermatol Clin"},{"key":"ref=5","first-page":"S21","volume":"12","author":"Shivasaraun U.V.","year":"2018","unstructured":"Shivasaraun U.V.; Sureshkumar R.; Karthika C.; Nethravathi P.; Vitiligo: A Review of its Aspects and Treatment Modalities. Asian J Pharm Sci 2018,12(1),S21-S30","journal-title":"Asian J Pharm Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jaad.2010.10.043","volume":"65","author":"Felsten L.M.","year":"2011","unstructured":"Felsten L.M.; Alikhan A.; Petronic-Rosic V.; Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment. J Am Acad Dermatol 2011,65(3),493-514","journal-title":"J Am Acad Dermatol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2147\/IJN.S105016","volume":"11","author":"Abdulbaqi I.M.","year":"2016","unstructured":"Abdulbaqi I.M.; Darwis Y.; Khan N.A.; Assi R.A.; Khan A.A.; Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomedicine 2016,11,2279-2304","journal-title":"Int J Nanomedicine"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","volume":"51","author":"Kr\u00fcger C.","year":"2012","unstructured":"Kr\u00fcger C.; Schallreuter K.U.; A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int J Dermatol 2012,51(10),1206-1212","journal-title":"Int J Dermatol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jaad.2018.11.047","volume":"80","author":"Vallerand I.A.","year":"2019","unstructured":"Vallerand I.A.; Lewinson R.T.; Parsons L.M.; Hardin J.; Haber R.M.; Lowerison M.W.; Barnabe C.; Patten S.B.; Vitiligo and major depressive disorder: A bidirectional population-based cohort study. J Am Acad Dermatol 2019,80(5),1371-1379","journal-title":"J Am Acad Dermatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ad.2017.03.007","volume":"108","author":"Morales-S\u00e1nchez M.A.","year":"2017","unstructured":"Morales-S\u00e1nchez M.A.; Vargas-Salinas M.; Peralta-Pedrero M.L.; Olgu\u00edn-Garc\u00eda M.G.; Jurado-Santa Cruz F.; Impacto del vit\u00edligo en la calidad de vida. Actas Dermosifiliogr 2017,108(7),637-642","journal-title":"Actas Dermosifiliogr"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","volume":"77","author":"Rodrigues M.","year":"2017","unstructured":"Rodrigues M.; Ezzedine K.; Hamzavi I.; Pandya A.G.; Harris J.E.; New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol Vitiligo Working Group2017,77(1),1-13","journal-title":"J Am Acad Dermatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s40257-017-0298-5","volume":"18","author":"Speeckaert R.","year":"2017","unstructured":"Speeckaert R.; van Geel N.; Vitiligo: An update on pathophysiology and treatment options. Am J Clin Dermatol 2017,18(6),733-744","journal-title":"Am J Clin Dermatol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"65","author":"Alikhan A.","year":"2011","unstructured":"Alikhan A.; Felsten L.M.; Daly M.; Petronic-Rosic V.; Vitiligo: A comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 2011,65(3),473-491","journal-title":"J Am Acad Dermatol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/01.EWX.0000450307.76457.a3","volume":"11","author":"Choi D.","year":"2014","unstructured":"Choi D.; Isedeh P.; Hamzavi I.H.; Vitiligo: A review of the pathogenesis. J Egypt Women Dermatol Soc 2014,11(3),145-158","journal-title":"J Egypt Women Dermatol Soc"},{"key":"ref=15","first-page":"585","author":"Ormsby O.","year":"1927","unstructured":"Ormsby O.;  Diseases of the skin 1927,585-589","journal-title":"Diseases of the skin"},{"key":"ref=16","first-page":"612","volume":"80","author":"Menon A.N.","year":"1945","unstructured":"Menon A.N.; Ultra-violet therapy in cases of leucoderma. Ind Med Gaz 1945,80(12),612-614","journal-title":"Ind Med Gaz"},{"key":"ref=17","first-page":"651","volume":"31","author":"Monem El Mofty A.","year":"1948","unstructured":"Monem El Mofty A.; A preliminary clinical report on the treatment of leucodermia with Ammi majus Linn. J Egypt Med Assoc 1948,31(8),651-665","journal-title":"J Egypt Med Assoc"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaad.2016.11.010","volume":"77","author":"Rodrigues M.","year":"2017","unstructured":"Rodrigues M.; Ezzedine K.; Hamzavi I.; Pandya A.G.; Harris J.E.; Current and emerging treatments for vitiligo. J Am Acad Dermatol Vitiligo Working Group2017,77(1),17-29","journal-title":"J Am Acad Dermatol"},{"author":"Bleuel R.","key":"ref=19","unstructured":"Bleuel R.; Therapeutisches Management bei Vitiligo Therapeutic management of vitiligo."},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.xphs.2016.10.001","volume":"106","author":"Jain S.","year":"2017","unstructured":"Jain S.; Patel N.; Shah M.K.; Khatri P.; Vora N.; Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. J Pharm Sci 2017,106(2),423-445","journal-title":"J Pharm Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3109\/10717544.2014.889777","volume":"22","author":"Pandey V.","year":"2015","unstructured":"Pandey V.; Golhani D.; Shukla R.; Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents. Drug Deliv 2015,22(8),988-1002","journal-title":"Drug Deliv"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/0024-3205(80)90268-4","volume":"26","author":"Mezei M.","year":"1980","unstructured":"Mezei M.; Gulasekharam V.; Liposomes-a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci 1980,26(18),1473-1477","journal-title":"Life Sci"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.2042-7158.1982.tb04767.x","volume":"34","author":"Mezei M.","year":"1982","unstructured":"Mezei M.; Gulasekharam V.; Liposomes-a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 1982,34(7),473-474","journal-title":"J Pharm Pharmacol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/02652049009040470","volume":"7","author":"Foldvari M.","year":"1990","unstructured":"Foldvari M.; Gesztes A.; Mezei M.; Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J Microencapsul 1990,7(4),479-489","journal-title":"J Microencapsul"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.2042-7158.1987.tb03407.x","volume":"39","author":"Kato A.","year":"1987","unstructured":"Kato A.; Ishibashi Y.; Miyake Y.; Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J Pharm Pharmacol 1987,39(5),399-400","journal-title":"J Pharm Pharmacol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-642-48391-2_13","author":"Bouwstra J.A.","year":"1992","unstructured":"Bouwstra J.A.; Hofland H.E.; Spies F.; Gooris G.S.; Junginger H.E.;  InLiposome Dermatics 1992,121-136","journal-title":"InLiposome Dermatics"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jconrel.2004.11.020","volume":"103","author":"Sinico C.","year":"2005","unstructured":"Sinico C.; Manconi M.; Peppi M.; Lai F.; Valenti D.; Fadda A.M.; Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J Control Release 2005,103(1),123-136","journal-title":"J Control Release"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.10.046","volume":"535","author":"Sala M.","year":"2018","unstructured":"Sala M.; Diab R.; Elaissari A.; Fessi H.; Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications. Int J Pharm 2018,535(1-2),1-17","journal-title":"Int J Pharm"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajps.2018.05.007","volume":"14","author":"Verma S.","year":"2019","unstructured":"Verma S.; Utreja P.; Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy. Asian J Pharm Sci 2019,14(2),117-129","journal-title":"Asian J Pharm Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1468-3083.2010.03701.x","volume":"25","author":"de Leeuw J.","year":"2011","unstructured":"de Leeuw J.; Assen Y.J.; van der Beek N.; Bjerring P.; Martino Neumann H.A.; Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation. J Eur Acad Dermatol Venereol 2011,25(1),74-81","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1089\/pho.2009.2637","volume":"28","author":"Asawanonda P.","year":"2010","unstructured":"Asawanonda P.; Klahan S.O.; Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study. Photomed Laser Surg 2010,28(5),679-684","journal-title":"Photomed Laser Surg"},{"author":"Nimmy J. K.","key":"ref=32","unstructured":"Nimmy J. K.; Krishnakumar D. B.; Smitha K. N.; ETHOSOMAL GEL: A REVIEW"},{"key":"ref=33","author":"Mishra K.K.","year":"2019","unstructured":"Mishra K.K.; Kaur C.D.; Verma S.; Sahu A.K.; Dash D.K.; Kashyap P.; Mishra S.P.;  InNanomedicines 2019","journal-title":"InNanomedicines"},{"year":"1998","author":"Touitou E.","key":"ref=34","unstructured":"Touitou E.; Composition for applying active substances to or through the skin 1998"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","volume":"65","author":"Touitou E.","year":"2000","unstructured":"Touitou E.; Dayan N.; Bergelson L.; Godin B.; Eliaz M.; Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000,65(3),403-418","journal-title":"J Control Release"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.rinphs.2011.10.002","volume":"1","author":"Chourasia M.K.","year":"2011","unstructured":"Chourasia M.K.; Kang L.; Chan S.Y.; Nanosized ethosomes bearing ketoprofen for improved transdermal delivery. Results Pharma Sci 2011,1(1),60-67","journal-title":"Results Pharma Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/1061186X.2015.1070855","volume":"24","author":"Garg B.J.","year":"2016","unstructured":"Garg B.J.; Garg N.K.; Beg S.; Singh B.; Katare O.P.; Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment. J Drug Target 2016,24(3),233-246","journal-title":"J Drug Target"},{"key":"ref=38","volume":"5","author":"Hamdan A.M.","year":"2015","unstructured":"Hamdan A.M.; Design, Formulation and Characterization of Liposomal Preparation of Voriconazole (VRC). J Pharm Biomed Sci 2015,5(10)","journal-title":"J Pharm Biomed Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijpharm.2014.06.001","volume":"471","author":"Zhang Y.T.","year":"2014","unstructured":"Zhang Y.T.; Shen L.N.; Wu Z.H.; Zhao J.H.; Feng N.P.; Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. Int J Pharm 2014,471(1-2),449-452","journal-title":"Int J Pharm"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/17425247.2017.1360863","volume":"15","author":"Lembo D.","year":"2018","unstructured":"Lembo D.; Donalisio M.; Civra A.; Argenziano M.; Cavalli R.; Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections. Expert Opin Drug Deliv 2018,15(1),93-114","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1517\/17425247.2012.686490","volume":"9","author":"Gupta M.","year":"2012","unstructured":"Gupta M.; Agrawal U.; Vyas S.P.; Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv 2012,9(7),783-804","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=42","first-page":"1","author":"Wadhwa S.","year":"2019","unstructured":"Wadhwa S.; Garg V.; Gulati M.; Kapoor B.; Singh S.K.; Mittal N.;  InPharmaceutical Nanotechnology 2019,1-17","journal-title":"InPharmaceutical Nanotechnology"},{"key":"ref=43","first-page":"2681","volume":"9","author":"Shaji J.","year":"2018","unstructured":"Shaji J.; Bajaj R.; Transethosomes: a New Prospect For Enhanced Transdermal Delivery. Int J Pharm Sci Res 2018,9(7),2681-2685","journal-title":"Int J Pharm Sci Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/08982104.2018.1517160","volume":"29","author":"Nainwal N.","year":"2019","unstructured":"Nainwal N.; Jawla S.; Singh R.; Saharan V.A.; Transdermal applications of ethosomes - a detailed review. J Liposome Res 2019,29(2),103-113","journal-title":"J Liposome Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.colsurfb.2011.12.004","volume":"92","author":"Song C.K.","year":"2012","unstructured":"Song C.K.; Balakrishnan P.; Shim C.K.; Chung S.J.; Chong S.; Kim D.D.; A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro\/in vivo evaluation. Colloids Surf B Biointerfaces 2012,92,299-304","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/21691401.2018.1469025","volume":"46","author":"Moolakkadath T.","year":"2018","unstructured":"Moolakkadath T.; Aqil M.; Ahad A.; Imam S. S.; Iqbal B.; Sultana Y.; Mujeeb M.; Iqbal Z.; Development of transethosomes formulation for dermal fisetin delivery: Box\u2013Behnken design, optimization, in vitro skin penetration, vesicles\u2013skin interaction and dermatokinetic studies Artif Cells Nanomed Biotechnol 2018,46(sup2),755-765","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1876402911666190603093550","volume":"12","author":"Kumar L.","year":"2020","unstructured":"Kumar L.; Utreja P.; Formulation and Characterization of Transethosomes for Enhanced Transdermal Delivery of Propranolol Hydrochloride. Micro Nanosyst 2020,12(1),38-47","journal-title":"Micro Nanosyst"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1208\/s12249-016-0489-z","volume":"18","author":"Garg V.","year":"2017","unstructured":"Garg V.; Singh H.; Bhatia A.; Raza K.; Singh S.K.; Singh B.; Beg S.; Systematic development of transethosomal gel system of piroxicam: formulation optimization, in vitro evaluation, and ex vivo assessment. AAPS PharmSciTech 2017,18(1),58-71","journal-title":"AAPS PharmSciTech"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/0005-2736(92)90154-E","volume":"1104","author":"Cevc G.","year":"1992","unstructured":"Cevc G.; Blume G.; Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992,1104(1),226-232","journal-title":"Biochim Biophys Acta"},{"key":"ref=50","first-page":"128","volume":"58","author":"Pirvu C.D.","year":"2010","unstructured":"Pirvu C.D.; Hlevca C.; Ortan A.; Prisada R.\u0102.; Elastic vesicles as drugs carriers through the skin. Farmacia 2010,58(2),128-135","journal-title":"Farmacia"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-662-47862-2_3","author":"Cevc G.","year":"2016","unstructured":"Cevc G.; Chopra A.;  InPercutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement 2016,39-59","journal-title":"InPercutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement"},{"key":"ref=52","first-page":"16","volume":"14","author":"Firoz S.","unstructured":"Firoz S.; A REVIEW ON TRANSFEROSOMES FOR TRANSDERMAL DRUG DELIVERY. Membranes ,14(15),16","journal-title":"Membranes"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/B978-0-12-813741-3.00021-2","author":"El Maghraby G.M.","year":"2018","unstructured":"El Maghraby G.M.; Arafa M.F.; Essa E.A.;  InApplications of Nanocomposite Materials in Drug Delivery 2018,469-490","journal-title":"InApplications of Nanocomposite Materials in Drug Delivery"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S2222-1808(12)60066-8","volume":"2","author":"Vinod K.R.","year":"2012","unstructured":"Vinod K.R.; Anbazhagan S.; Kumar M.S.; Sandhya S.; Banji D.; Rani A.P.; Developing ultra deformable vesicular transportation of a bioactive alkaloid in pursuit of vitiligo therapy. Asian Pac J Trop Dis 2012,2(4),301-306","journal-title":"Asian Pac J Trop Dis"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jphotobiol.2017.07.007","volume":"174","author":"Doppalapudi S.","year":"2017","unstructured":"Doppalapudi S.; Mahira S.; Khan W.; Development and in vitro assessment of psoralen and resveratrol co-loaded ultradeformable liposomes for the treatment of vitiligo. J Photochem Photobiol B 2017,174,44-57","journal-title":"J Photochem Photobiol B"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jddst.2019.02.033","volume":"52","author":"Mahira S.","year":"2019","unstructured":"Mahira S.; Kommineni N.; Doppalapudi S.; Khan W.; Edge activated ultradeformable liposomes of psoralen and its derivatives: Development and comparative evaluation for vitiligo therapy. J Drug Deliv Sci Technol 2019,52,83-95","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.colsurfb.2018.12.055","volume":"175","author":"Mir-Palomo S.","year":"2019","unstructured":"Mir-Palomo S.; N\u00e1cher A.; Ofelia Vila Bus\u00f3 M.A.; Caddeo C.; Manca M.L.; Manconi M.; D\u00edez-Sales O.; Baicalin and berberine ultradeformable vesicles as potential adjuvant in vitiligo therapy. Colloids Surf B Biointerfaces 2019,175,654-662","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3109\/10717544.2012.724472","volume":"19","author":"Bragagni M.","year":"2012","unstructured":"Bragagni M.; Mennini N.; Maestrelli F.; Cirri M.; Mura P.; Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib. Drug Deliv 2012,19(7),354-361","journal-title":"Drug Deliv"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10856-015-5487-2","volume":"26","author":"Guo F.","year":"2015","unstructured":"Guo F.; Wang J.; Ma M.; Tan F.; Li N.; Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation. J Mater Sci Mater Med 2015,26(4),175","journal-title":"J Mater Sci Mater Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.2147\/IJN.S86186","volume":"10","author":"Ascenso A.","year":"2015","unstructured":"Ascenso A.; Raposo S.; Batista C.; Cardoso P.; Mendes T.; Pra\u00e7a F.G.; Bentley M.V.; Sim\u00f5es S.; Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes. Int J Nanomedicine 2015,10,5837-5851","journal-title":"Int J Nanomedicine"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08982104.2014.950276","volume":"25","author":"Ahmed T.A.","year":"2015","unstructured":"Ahmed T.A.; Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett-Burman design and characterization. J Liposome Res 2015,25(1),1-10","journal-title":"J Liposome Res"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08982100902788408","volume":"19","author":"Maestrelli F.","year":"2009","unstructured":"Maestrelli F.; Capasso G.; Gonz\u00e1lez-Rodr\u00edguez M.L.; Rabasco A.M.; Ghelardini C.; Mura P.; Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. J Liposome Res 2009,19(4),253-260","journal-title":"J Liposome Res"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/591325","author":"Wagner A.","year":"2011","unstructured":"Wagner A.; Vorauer-Uhl K.; Liposome technology for industrial purposes.  J Drug Deliv 2011","journal-title":"J Drug Deliv"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0005-2736(79)90085-3","volume":"557","author":"Olson F.","year":"1979","unstructured":"Olson F.; Hunt C.A.; Szoka F.C.; Vail W.J.; Papahadjopoulos D.; Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta 1979,557(1),9-23","journal-title":"Biochim Biophys Acta"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.3109\/03639049409042681","volume":"20","author":"Schneider T.","year":"1994","unstructured":"Schneider T.; Sachse A.; R\u00f6bling G.; Brandl M.; Large-scale production of liposomes of defined size by a new continuous high pressure extrusion device. Drug Dev Ind Pharm 1994,20(18),2787-2807","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118817","volume":"573","author":"Fern\u00e1ndez-Garc\u00eda R.","year":"2020","unstructured":"Fern\u00e1ndez-Garc\u00eda R.; Lalatsa A.; Statts L.; Bol\u00e1s-Fern\u00e1ndez F.; Ballesteros M.P.; Serrano D.R.; Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale. Int J Pharm 2020,573","journal-title":"Int J Pharm"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1213\/ANE.0000000000001200","volume":"122","author":"Davidson E.M.","year":"2016","unstructured":"Davidson E.M.; Haroutounian S.; Kagan L.; Naveh M.; Aharon A.; Ginosar Y.; A novel proliposomal ropivacaine oil: Pharmacokinetic\u2013pharmacodynamic studies after subcutaneous administration in pigs. Anesth Analg 2016,122(5),1663-1672","journal-title":"Anesth Analg"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00216-011-5415-3","volume":"402","author":"Golden J.P.","year":"2012","unstructured":"Golden J.P.; Justin G.A.; Nasir M.; Ligler F.S.; Hydrodynamic focusing--a versatile tool. Anal Bioanal Chem 2012,402(1),325-335","journal-title":"Anal Bioanal Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"25876","DOI":"10.1038\/srep25876","volume":"6","author":"Carugo D.","year":"2016","unstructured":"Carugo D.; Bottaro E.; Owen J.; Stride E.; Nastruzzi C.; Liposome production by microfluidics: potential and limiting factors. Sci Rep 2016,6,25876","journal-title":"Sci Rep"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1021\/la703509r","volume":"24","author":"Sugiura S.","year":"2008","unstructured":"Sugiura S.; Kuroiwa T.; Kagota T.; Nakajima M.; Sato S.; Mukataka S.; Walde P.; Ichikawa S.; Novel method for obtaining homogeneous giant vesicles from a monodisperse water-in-oil emulsion prepared with a microfluidic device. Langmuir 2008,24(9),4581-4588","journal-title":"Langmuir"},{"year":"2015","author":"Jaafari M.R.","key":"ref=71","unstructured":"Jaafari M.R.; Khamesipour A.; Topical liposomes compositions for delivering hydrophobic drugs and methods preparing same. 2015"},{"year":"2003","author":"Bodmer D.","key":"ref=72","unstructured":"Bodmer D.; Kissel T.; Richter F.; Tiemessen H.; Allylamine-containing liposomes. 2003"},{"year":"2010","author":"Cvec G.","key":"ref=73","unstructured":"Cvec G.; Vierl U.;  Topical terbinafine formulations and methods of administering same for the treatment of fungal infections. 2010"},{"year":"1999","author":"Touitou E.","key":"ref=74","unstructured":"Touitou E.; Compositions for applying active substances to or through the skin. 1999"},{"year":"2012","author":"Yan M.G.","key":"ref=75","unstructured":"Yan M.G.; Shu M.; Jianxin L.D.; Ethosome preparation of male hormone medicaments and its preparation method. 2012"},{"year":"2013","author":"Shu Z.","key":"ref=76","unstructured":"Shu Z.; Hong D.; Huaqing L.; Xiaoling Z.; Progesterone ethosome, and preparation method and application thereof. 2013"},{"year":"2012","author":"Wen W.","key":"ref=77","unstructured":"Wen W.; Yan X.; Acyclovir ethosome and preparation method thereof. 2012"},{"year":"2015","author":"Man L.","key":"ref=78","unstructured":"Man L.; Yong L.; Clotrimazole ethosomes for preventing and curing weaning rabbit dermatomycosis and preparation method thereof. 2015"},{"year":"2013","author":"Jianping T.","key":"ref=79","unstructured":"Jianping T.; Lixin J.; Zhiwen Z.; Bullatacin ethosome gel and preparation method thereof. 2013"},{"year":"2015","author":"Maalawy M.","key":"ref=80","unstructured":"Maalawy M.; Transdermal composition for treating pain.  2015"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s13346-019-00653-y","volume":"9","author":"Shaaban M.","year":"2019","unstructured":"Shaaban M.; Nasr M.; Tawfik A.A.; Fadel M.; Sammour O.; Novel bergamot oil nanospanlastics combined with PUVB therapy as a clinically translatable approach for vitiligo treatment. Drug Deliv Transl Res 2019,9(6),1106-1116","journal-title":"Drug Deliv Transl Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2147\/IJN.S57314","volume":"9","author":"Zhang Y.T.","year":"2014","unstructured":"Zhang Y.T.; Shen L.N.; Zhao J.H.; Feng N.P.; Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis. Int J Nanomedicine 2014,9,669-678","journal-title":"Int J Nanomedicine"}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/187760","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/187760\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/187760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:57:10Z","timestamp":1746572230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/187760\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8,16]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467213999201109220714","relation":{},"ISSN":["1874-4672"],"issn-type":[{"type":"print","value":"1874-4672"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}